Compare ATRC & LNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | LNN |
|---|---|---|
| Founded | 2000 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2005 | 1995 |
| Metric | ATRC | LNN |
|---|---|---|
| Price | $28.17 | $108.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $51.17 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 769.9K | 153.4K |
| Earning Date | 05-05-2026 | 04-02-2026 |
| Dividend Yield | N/A | ★ 1.35% |
| EPS Growth | ★ 74.74 | 12.81 |
| EPS | N/A | ★ 2.70 |
| Revenue | $201,630,000.00 | ★ $676,368,000.00 |
| Revenue This Year | $15.27 | N/A |
| Revenue Next Year | $12.21 | $4.74 |
| P/E Ratio | ★ N/A | $40.49 |
| Revenue Growth | ★ 15.40 | 11.41 |
| 52 Week Low | $25.52 | $97.27 |
| 52 Week High | $43.18 | $149.56 |
| Indicator | ATRC | LNN |
|---|---|---|
| Relative Strength Index (RSI) | 49.86 | 48.10 |
| Support Level | $26.47 | $106.63 |
| Resistance Level | $30.75 | $115.75 |
| Average True Range (ATR) | 1.36 | 3.43 |
| MACD | 0.20 | 0.29 |
| Stochastic Oscillator | 69.14 | 47.87 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.